Published on:

Oral contraceptive concerns spur investigations

The New York Times is reporting that oral contraceptives Yaz and Yasmine are highly marketed because the product marketing presents them as much more than mere pregnancy prevention. The Yaz’s image has been clouded by concern that the drug puts women at higher risk for personal injuries such as blood clots, strokes, and other health problems.

To read more about the oral contraceptive concerns.